• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Exagen Inc. - Common Stock (NQ:XGN)

    6.305 +1.625 (+34.72%)
    Streaming Delayed Price Updated: 2:03 PM EDT, Aug 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,887,471
    Open 5.750
    Bid (Size) 6.290 (100)
    Ask (Size) 6.320 (400)
    Prev. Close 4.680
    Today's Range 5.740 - 6.830
    52wk Range 2.590 - 12.23
    Shares Outstanding 16,126,784
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Top movers in Tuesday's session ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Tuesday's session. ↗
    Via Chartmill

    Performance

    YTD
    +4.4%
    +4.4%
    1 Month
    +43.3%
    +43.3%
    3 Month
    +103.4%
    +103.4%
    6 Month
    +64.6%
    +64.6%
    1 Year
    -28.8%
    -28.8%

    More News

    Read More
    Exagen (NASDAQ:XGN) Beats Q2 Estimates and Raises Full-Year Guidance ↗
    Via Chartmill
    Tuesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Exagen Inc. Reports Second Quarter 2026 Financial Results
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. (NASDAQ:XGN) Soars on Q1 2026 Earnings Beat as Record Revenue and Narrowed Loss Fuel Pre-Market Rally ↗
    Via Chartmill
    Topics Earnings
    Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Exagen Inc. to Participate in Upcoming Investor Conference
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen to Announce Second Quarter Financial Results on August 4, 2026
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen (XGN) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Exagen Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Exagen Inc. Reports First Quarter 2026 Results
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen Inc. to Participate in Upcoming Investor Conferences
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen Inc. Announces Select Preliminary 2025 Financial Results
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen Inc. to Participate in Fourth Quarter Investor Conferences
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Exagen Inc. (NASDAQ:XGN) Reports Mixed Q3 2025 Results with Revenue Beat and Wider-Than-Expected Loss ↗
    Via Chartmill
    News headline image
    Exagen Inc. Reports Strong Q3 2025 Results
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday ↗
    Via Benzinga
    News headline image
    Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
    From Exagen Inc.
    Via GlobeNewswire
    News headline image
    Demystifying Exagen: Insights From 5 Analyst Reviews ↗
    Via Benzinga

    Frequently Asked Questions

    Is Exagen Inc. - Common Stock publicly traded?
    Yes, Exagen Inc. - Common Stock is publicly traded.
    What exchange does Exagen Inc. - Common Stock trade on?
    Exagen Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Exagen Inc. - Common Stock?
    The ticker symbol for Exagen Inc. - Common Stock is XGN on the Nasdaq Stock Market
    What is the current price of Exagen Inc. - Common Stock?
    The current price of Exagen Inc. - Common Stock is 6.305
    When was Exagen Inc. - Common Stock last traded?
    The last trade of Exagen Inc. - Common Stock was at 08/04/26 02:03 PM ET
    What is the market capitalization of Exagen Inc. - Common Stock?
    The market capitalization of Exagen Inc. - Common Stock is 101.68M
    How many shares of Exagen Inc. - Common Stock are outstanding?
    Exagen Inc. - Common Stock has 102M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.